(Press-News.org) CINCINNATI - Researchers have identified a biological basis for asthmatic children who do not respond well to corticosteroid treatment - currently the most effective treatment for chronic asthma and acute asthma attack.
Conducted at Cincinnati Children's Hospital Medical Center, the study also identifies a genetic pathway that could open the possibility of new therapies for difficult-to-treat patients. The findings are reported April 21 in The Journal of Allergy and Clinical Immunology, published by the American Academy of Allergy Asthma and Immunology.
The researchers performed genome-wide analysis of nasal epithelial cells collected from children experiencing acute asthma exacerbation. They compared genetic expression and medical responses in children who responded well to corticosteroids therapy to those who did not.
"Genome-wide analysis allowed us to identify a gene, VNN-1, whose expression discriminated between good and poor responders to systemic corticosteroid treatment," said Gurjit Khurana Hershey, MD, PhD, senior author and director of Asthma Research at Cincinnati Children's. "This may serve as a clinically useful biomarker to identify a subset of difficult-to-treat asthmatic children, and targeting the VNN-1 pathway may be useful as a therapeutic strategy."
Asthma affects close to 26 million people in the United States, 7 million of them children. Although people suffering from asthma share similar clinical symptoms, it is triggered by multiple genetic and environmental factors. This makes asthma a series of respiratory syndromes that can be difficult to study and treat and personalized therapeutic management is needed to achieve the best outcomes, according to the researchers.
Less-than-optimal management of childhood asthma is highlighted by the fact that nearly two-thirds of asthmatic children report at least one attack a year. And researchers estimate that effective treatment is either absent or incomplete in 40-70 percent of cases, highlighting the need for new treatment strategies. This includes the subset of children who do not respond well to systemic corticosteroid therapy.
"Difficult-to-treat patients account for over 50 percent of health care costs associated with asthma," Hershey said. "There are new drugs that may be helpful, as well as those that affect the VNN-1 pathway, but they have not been tested in asthma. This study provides the basis for a biomarker to determine which patients might be best to target with new treatments."
The study included 57 children between ages 5 and 18 who were admitted through the Emergency Department at Cincinnati Children's and hospitalized for treatment of their asthma. In an initial group of patients experiencing asthma attack, nasal epithelia cells were collected and tested for comparative VNN-1 expression. Researchers then tested a second group of patients to verify results of the first group.
Starting with a candidate list of 20,000 genes, researchers screened down to eight before singling out VNN-1 as the primary target. They conducted a series of cell biology tests in the lab to show that VNN-1 expression is required for inhaled corticoids to work during asthma attack. In cells from patients whose asthma did not respond well to treatment, researchers found a biochemical variation in the VNN-1 molecular network that hindered its expression.
The researchers next tested and confirmed their clinical findings in laboratory mouse models of asthma, and produced data suggesting that targeting the VNN-1 pathway therapeutically might be a way to improve outcomes for difficult-to-treat asthmatic children.
Testing continues in laboratory models to better determine the VNN-1 pathway's role in contributing to airway inflammation and hyper-responsiveness in asthma. Researches are also testing drugs that target the VNN-1 pathway to determine which, if any, might improve treatment for asthmatic children who do not respond to current treatments.
Enhanced expression of VNN-1 is associated with multiple human diseases, such as inflammatory bowel disease, immune thrombocytopenia and system lupus erythematosus. This is the first study to report improperly regulated expression of VNN-1 and its mRNA (which help translate and transmit genetic information) in asthma.
INFORMATION:
Collaborating with Hershey were first author, Chang Xiao, MD, PhD, a member of Hershey's laboratory team, and researchers from the divisions of Allergy and Immunology, Human Genetics, Hospital Medicine, Emergency Medicine and Pulmonary Medicine at Cincinnati Children's, and the Department of Pediatrics at the University of Cincinnati College of Medicine.
Funding support for the study came from the National Institutes of Health (2U19AI70235, R21AI101375 and T32 ES010957).
About Cincinnati Children's:
Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News & World Report's 2014 Best Children's Hospitals. It is also ranked in the top 10 for all 10 pediatric specialties. Cincinnati Children's, a non-profit organization, is one of the top three recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at http://www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.
In a new study published today in the British Journal of Nutrition, a team of researchers led by the University of Surrey, has found that front of package nutrition labels can enable consumers to make healthier food choices.
In recent years, a number of different front of package labels have been developed by industry and health promotion organisations. The majority of labels include values for energy, sugar, fat, saturated fat and salt, but some also include percentage Guideline Daily Amounts or traffic light colours to help consumers' understanding of the numerical ...
Preliminary findings presented at international TB vaccine conference suggest development and introduction of a "post-infection" vaccine could have a major impact in reducing TB disease in China
WHO currently estimates nearly 1 million new cases of TB in China every year
SHANGHAI (21 April 2015)--A major contributor to the number of tuberculosis infections and cases in China will likely be the elderly over the next few decades, requiring a refocus in efforts to control a disease affecting millions of people in the country, according to preliminary new research presented ...
In the 1950s computers were giant machines that filled buildings and served a variety of arcane functions. Today they fit into our pockets or backpacks, and help us work, communicate and play.
"Biotechnology today it is very similar to where computing technology used to be," said Ingmar Riedel-Kruse, an assistant professor of bioengineering at Stanford.
"Biological labs are housed in big buildings and the technology is hard to access," he added. "But we are changing that. We are enabling people to interact with biological materials and perform experiments the way they ...
PHILADELPHIA (April 21, 2015) - New research from the Monell Center reveals that tumor necrosis factor (TNF), an immune system regulatory protein that promotes inflammation, also helps regulate sensitivity to bitter taste. The finding may provide a mechanism to explain the taste system abnormalities and decreased food intake that can be associated with infections, autoimmune disorders, and chronic inflammatory diseases.
In addition to its role in mediating inflammation, TNF has been implicated in the progression of varied diseases ranging from Alzheimer's disease ...
*World-first: MRI used to study infant pain
*Finds 18 of 20 brain 'pain' regions activate in adults are active in babies
*Also suggests infants are more sensitive to pain than adults
*Highlights need to review pain relief for babies
The brains of babies 'light up' in a very similar way to adults when exposed to the same painful stimulus, a pioneering Oxford University brain scanning study has discovered. It suggests that babies experience pain much like adults.
The study looked at 10 healthy infants aged between one and six days old and 10 healthy adults aged ...
In research published today in the journal Cerebral Cortex, a team of scientists led by the University of Cambridge and the Medical Research Council (MRC) Cognition and Brain Sciences Unit, Cambridge, studied not only whether volunteers could be trained to follow their heartbeat, but whether it was possible to identify from brain activity how good they were at estimating their performance.
Dr Tristan Bekinschtein, a Wellcome Trust Fellow and lecturer in the Department of Psychology at the University of Cambridge, says: "'Follow your heart' has become something of a cliché, ...
Dutch doctors withhold/withdraw treatment in a substantial proportion of elderly patients, reveals research published online in the Journal of Medical Ethics.
But their decisions don't seem to be driven by ageism; rather, they are more likely based on considerations of comfort and respect and the avoidance of futile treatment, conclude the researchers.
In a bid to assess whether certain age groups are more likely to have treatment withheld or withdrawn, the researchers looked at a sample of deaths, stratified according to whether end of life decisions were likely or ...
UK doctors are unlikely to be able to repay their student loans over the course of their working lives, amassing debts of more than £80,000 by the time they graduate, in some cases, finds research published in the online journal BMJ Open.
What's more, there are clear gender differences in the amount of cash required to service these debts, the analysis shows, with women paying more in interest, despite earning less than men.
The researchers base their findings on the average earnings of 4286 doctors working more than 30 hours a week, who had taken part in national ...
Mindfulness-based cognitive therapy (MBCT) could provide an alternative non-drug treatment for people who do not wish to continue long-term antidepressant treatment, suggests new research published in The Lancet.
The results come from the first ever large study to compare MBCT - structured training for the mind and body which aims to change the way people think and feel about their experiences - with maintenance antidepressant medication for reducing the risk of relapse in depression.
The study aimed to establish whether MBCT is superior to maintenance antidepressant ...
TORONTO, ON, April 20, 2015 -- South Asian women are more likely to be diagnosed with later stage breast cancer compared to the general population, while Chinese women are more likely to be diagnosed with early stage cancer, according to a new study by Women's College Hospital and the Institute for Clinical Evaluative Sciences (ICES).
The findings, published today in the journal Current Oncology, confirm a strong link between ethnicity and breast cancer stage at diagnosis for Canadian women. An editorial by Dr. Aisha Lofters accompanies the paper and indicates that the ...
